|
|
|
|
All Topics - Quest Diagnostics Patient Health Library
- Learning Disability / Attention Deficit Disorder - [Support Group] - Feissinger-Leroy-Reiter Syndrome - Felbamate for epilepsy - [Medication] - Felty Syndrome - Female Genital Prolapse - Female Pseudo-Turner Syndrome - Femoral Dysgenesis, Bilateral - Femoral Dysgenesis, Bilateral-Robin Anomaly - Femoral Facial Syndrome Top Femoral Hypoplasia-Unusual Facies Syndrome -...
|
|
|
Teva Pharmaceutical Industries - News and PR
- - Search Tevapharm: - - Press Releases 2004 - 2005: Teva Announces Approval Of Methylprednisolone Acetate Injectable Suspension Jerusalem, Israel, February 24, 2005 Teva and Lundbeck Announce European Approval for AZILECT® (rasagiline) 1mg for Parkinson's Disease Jerusalem, Israel and Copenhagen, Denmark, February 22, 2005 Teva Announces Settlement Of Lamictal® Litigation...
|
|
|
Teva Pharmaceutical Industries - News and PR
- - Search Tevapharm: - - Press Release Teva Announces Approval Of Fludarabine Phosphate Injection Jerusalem, Israel, April 29, 2004 - Teva Pharmaceutical Industries Ltd.
Food and Drug Administration has granted approval for an ANDA for Fludarabine Phosphate Injection, 25 mg/ml, which was submitted by the Company’s subsidiary Sicor Inc.
Shipment of...
|
|
|
http://www.fda.gov/cder/orange/appendix_a.txt
RTU IN PLASTIC CONTAINER, METRONIDAZOLE FLAGYL I.V., METRONIDAZOLE HYDROCHLORIDE FLAGYL, METRONIDAZOLE FLAREX, FLUOROMETHOLONE ACETATE FLAVORED COLESTID, COLESTIPOL HYDROCHLORIDE FLAVOXATE HCL, FLAVOXATE HYDROCHLORIDE FLAXEDIL, GALLAMINE TRIETHIODIDE FLECAINIDE ACETATE, FLECAINIDE ACETATE FLEXERIL, CYCLOBENZAPRINE HYDROCHLORIDE FLEXICORT, HYDROCORTISONE FLOLAN, EPOPROSTENOL SODIUM...
|
|
|
EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2003
*Supplement Type Description for SE1 - SE7 N (Chemical Type 6) SE1 SE2 SE3 SE4 SE5 SE6 SE7 NDA Type 6 - New Indication New or modified indication New dosage regimen New route of administration Comparative efficacy claim Patient population altered Change the marketing status from prescription to over the counter use Complete the traditional approval of a product originally approved...
|
|
|
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt
IN MILAN, ITALY" 8241 06-Oct-89 ASH STEVENS INC "FLUDARABINE PHOSPHATE AS MFG
OF IRELAND" 13266 05-Oct-98 FABBRICA ITALIANA SINTETICI SPA "NITROFURANTOIN MONHYDRATE, MANUFACTURED IN VICENZA, ITALY" 13277 22-Oct-98 MATRIX LABORATORIES LIMITED "ACYCLOVIR USP, MANUFACTURED IN ANDHRA PRADESH, INDIA" 13279 19-Oct-98 SYLACHIM DIV FINORGA "LEVOBETAXOLOL HYDROCHLORIDE,...
|
|
|
OGD Suitability Tracking Reports (Sorted by Petition Number) as of 1/5/2004
- TABLET; ORAL Approved 2/28/2003- BACLOFEN 10 mg, 20 mg - 02P-0078/CP1 KLEINFELD, KAPLAN & BECKER - ORALLY DISINTEGRATING TABLETS Approved 2/5/2003- OXYCODONE 5mg, 7.5mg, 10mg ACETAMINOPHEN 300mg - 02P-0105/CP1 LACHMAN CONSULTANT SERVICES - TABLETS Approved 8/6/2002- CARISOPRODOL 350 mg - 02P-0138/CP1 LACHMAN CONSULTANT SERVICES - ORALLY DISINTEGRATING TABLETS Withdrawn 7/25/2002-...
|
|
|
OGD Suitability Tracking Reports (Sorted by Drug Name) as of 1/5/2004
- INJECTION Approved 8/13/2003- ESTROPIPATE 1.2 mg - 02P-0141/CP1 WOMEN FIRST HEALTHCARE - TABLETS Approved 9/24/2002- ETHINYL ESTRADIOL 0.035 MG NORETHINDRONE 0.4 MG - 99P-1150/CP1 KIRKLAND & ELLIS - TABLET; CHEWABLE Approved 4/14/2000- FAMOTIDINE 10MG - 00P-1422/CP1 YAMANOUCHI PHARMA TECHNOLOGIES - TABLET; ORALLY DISINTEGRATING Approved 4/17/2001- FENOFIBRATE 107 mg - 02P-0148/CP1...
|
|
|
Prescription and Over-the-Counter Drug Product List: 8/2003
4 >D> AA + ORTHO MCNEIL PHARM 300MG;60MG N85055 004 AUG DISC >A> @ 300MG;60MG N85055 004 AUG DISC ACETAMINOPHEN; HYDROCODONE BITARTRATE SOLUTION; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN >A> AA + MALLINCKRODT 500MG/15ML;10MG/15ML N40508 001 AUG 29, 2003 AUG NEWA >D> MIKART 500MG/15ML;5MG/15ML N81226 001 OCT 27, 1992 AUG CTEC >A> AA 500MG/15ML;5MG/15ML N81226 001 OCT 27, 1992 AUG...
author: AUTHOR
|
|
|
ANDA Approvals - August 2003
- FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -Approvals - August 2003 - ANDA Number Generic Drug Name Applicant Approval Date 1 65-080 AMOXICILLIN TABLETS FOR ORAL SUSPENSION 200 MG AND 400 MG - RANBAXY LABORATORIES LIMITED 8/11/2003- 2 76-134 LORATADINE TABLETS (OTC) 10 MG - RANBAXY LABORATORIES LIMITED 8/18/2003- 3 76-453 LIDOCAINE...
|
|
|
Generic Tentative Approvals - March 2003
Food and Drug Administration • Center for Drug Evaluation and Research Drug Information Search Tentative Approvals - March 2003 - ANDA Number Generic Drug Name Applicant Tentative Approval Date 1 76-214 SOTALOL HYDROCHLORIDE TABLETS (AF) 80 MG, 120 MG, AND 160 MG TORPHARM 3/5/2003- 2 76-349 FLUDARABINE PHOSPHATE FOR INJECTION 50 MG/VIAL GENSIA SICOR PHARMACEUTICALS,...
author: OGD
|
|
|
rld_labeling_approved_may_1999
Firm Date ISUPREL Isoproterenol Hydrochloride Injection 10-515 S-022 Abbott 4-May-1999 PATINOL /PLATINOL-AQ Cisplatin For Injection/Cisplatin Injection 18-057 S-068 Bristol Myers Squibb 5-May-1999 MAXAQUIN Lomefolxacin Hydrochloride 20-013 S-013 Searle 6-May-1999 URACIL MUSTARD Uracil Mustard capsules 12-892 S-001 Roberts Labs 6-May-1999 ESTROSTEP Norethindrone acetate/ethinyl...
|
|
|
FDA Drug Approvals List December 2001
Active Ingredient(s): LISINOPRIL OTC/RX Status: RX Original Abbreviated Application #: 076058 Tentative Approval Date: 21-DEC-01 Trade Name: MIDAZOLAM HCL Dosage Form: SYRUP Applicant: RANBAXY LABORATORIES LTD Active Ingredient(s): MIDAZOLAM HYDROCHLORIDE OTC/RX Status: RX Original Abbreviated Application #: 076134 Tentative Approval Date: 20-DEC-01 Trade Name: LORATADINE Dosage Form...
|
|
|
http://www.fda.gov/cder/da/ddpa91.wpd
DEPARTMENT OF HEALTH AND HUMAN SERVICES, PUBLIC HEALTH SERVICE NDA NUMBER APPROVAL DATE (CLASSIFICATION)TRADE NAME (DOSAGE FORM)APPLICANTACTIVE INGREDIENT(S) STRENGTH(S) CLASSIFICATION(S) ***ORIGINAL AND SUPPLEMENTAL NDAs*** FOR NEW DRUG PRODUCTS 20 057 CEREDASE GENZYME ALGLUCERASE 04 05-91 (INJECTABLE) BOSTON, MA 80 UNITS/ML (1 A, V*) 02111 (BETA-GLUCOCEREBROSIDASE ENZYME...
|
|
|
BioCryst Pharmacueticals - structure based drug design and crystallography
(Seasonal/Life Threatening Influenza) Forodesine HCl (CTCL) Forodesine HCl (Chronic Lymphocytic Leukemia) BCX-4208 - Oral (Psoriasis) - Clinical Trials - Peramivir - A Phase II Study to Evaluate the Efficacy and Safety of Intramuscular Peramivir in Subjects with Uncomplicated Acute Influenza A Phase II Study Comparing the Efficacy and Safety of Peramivir Administered Intravenously...
|
|
|
Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
|
|
|
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
|
|
|
Chemotherapy: Prevention and Treatment of Cancer: Merck Manual Home Edition
Chemotherapy Drugs Class Examples How the Drug Works Side Effects Alkylating agents - Cyclophosphamide Chlorambucil Melphalan Form chemical bond with DNA, causing breaks in DNA and errors in replication of DNA Suppress bone marrow, injure lining of stomach, cause hair loss; may decrease fertility Antimetabolites - Methotrexate Cytarabine Fludarabine 6-Mercaptopurine 5...
|
|
|
Index: FL: Merck Manual Home Edition
Flow rate (lung) Using a Spirometer Flow volume (lung) Diagnosis: Flow Volume Testing Flu respiratory see Influenza stomach see Gastroenteritis Fluconazole Drugs for Serious Fungal Infections Flucytosine Drugs for Serious Fungal Infections Fludarabine Chemotherapy Drugs Fludrocortisone Orthostatic Hypotension: Treatment Addison's Disease: Treatment Fluid retention see Swelling ...
|
|
|
THE MERCK MANUAL OF GERIATRICS, Index F
- Index Index-A -| Index-B -| Index-C -| Index-D -| Index-E -| Index-F -| Index-G -| Index-H -| Index-I -| Index-J &n; bsp;| Index-K -| Index-L -| Index-M -| Index-N -| Index-O -| Index-P -| Index-Q -| Index-R -| Index-S -| Index-T -| Index-U -| Index-V -| Index-W -| Index-X,Y,Z Index F Face in parkinsonism 435 in physical examination 32 Face-life (rhytidectomy) 1238 Factitious...
|
|
|
Welcome to Genta Incorporated
- - Genasense ® is a drug that inhibits the production of a protein known as Bcl-2.
This process is known as programmed cell death or apoptosis.
Genta's clinical trials programs focus on pretreating cancer patients with Genasense prior to the administration of anticancer therapy with the intention of potentiating the cancer-killing effects of treatment.
Genta is...
|
